Circulating Tumor Cells Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2032

1.1 Research Objective

1.2 Product Overview

1.3 Market Segmentation

2.1 Qualitative Research
2.1.1 Primary & Secondary Sources

2.2 Quantitative Research
2.2.1 Primary & Secondary Sources

2.3 Breakdown of Primary Research Respondents, By Region

2.4 Assumption for the Study

2.5 Market Size Estimation

2.6. Data Triangulation

Executive Summary: Global Circulating Tumor Cells Market

4.1. Industry Value Chain Analysis
4.1.1. Material Provider
4.1.2. Designing and Manufacturer
4.1.3. Distributor
4.1.4. End Users

4.2. Industry Outlook
4.2.1. Top Liquid Biopsy Startup 

4.3. PESTLE Analysis

4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition

4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Challenges
4.5.4. Key Trends

4.6. Covid-19 Impact Assessment on Market Growth Trend

4.7. Market Growth and Outlook
4.7.1. Market Revenue Estimates and Forecast (US$ Bn), 2019 - 2032
4.7.2. Price Trend Analysis

4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2023
4.8.3. Competitor Mapping

5.1. Key Insights

5.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
5.2.1. CTC Detection & Enrichment Methods
5.2.1.1. Label-based Technologies 
5.2.1.1.1. Magnetic nanoparticles
5.2.1.1.2. Immunogenetic Beads 
5.2.1.1.2.1. Positive enrichment
5.2.1.1.2.2. Negative enrichment
5.2.1.1.3. Microfluidics Devices
5.2.1.1.4. Dual Modility
5.2.1.1.5. Others
5.2.1.2. Label-free  Technologies
5.2.1.2.1. Microfiltration
5.2.1.2.2. Density gradient centrifugation
5.2.1.2.3. Inertial Focusing
5.2.1.2.4. Direct Imaging
5.2.1.2.5. Dielectrophoresis
5.2.2. Advanced CTC Detection Technologies
5.2.2.1. RT-PCR (reverse transcriptase polymerase chain reaction)
5.2.2.2. Immunofluorescence and immunocytochemistry
5.2.2.3. FISH (fluorescence in situ hybridization)
5.2.2.4. SE-iFISH (immunostaining-FISH combined with subtraction enrichment)
5.2.2.5. FACS (fluorescence assisted cell sorting)

6.1. Key Insights

6.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
6.2.1. Blood
6.2.2. Bone Marrow
6.2.3. Other Body Fluids

7.1. Key Insights

7.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
7.2.1. Kits & Reagents
7.2.2. Blood Collection Tubes
7.2.3. Devices or Systems

8.1. Key Insights

8.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
8.2.1. Clinical/Liquid Biopsy
8.2.1.1. Risk Assessment
8.2.1.2. Screening and Monitoring
8.2.2. Research
8.2.2.1. Cancer Stem Cell & Tumorigenesis Research
8.2.2.2. Drug/Therapy Development

9.1. Key Insights

9.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
9.2.1. North America 
9.2.1.1. The U.S.
9.2.1.2. Canada
9.2.1.3. Mexico
9.2.2. Europe
9.2.2.1. The UK
9.2.2.2. Germany
9.2.2.3. France
9.2.2.4. Spain
9.2.2.5. Russia
9.2.2.6. Rest of Europe
9.2.3. Asia Pacific
9.2.3.1. China
9.2.3.2. India
9.2.3.3. Japan
9.2.3.4. Australia & New Zealand
9.2.3.5. South Korea
9.2.3.6. ASEAN
9.2.3.7. Rest of Asia Pacific
9.2.4. Middle East & Africa (MEA)
9.2.4.1. UAE
9.2.4.2. Saudi Arabia
9.2.4.3. Rest of MEA
9.2.5. South America
9.2.5.1. Argentina
9.2.5.2. Brazil
9.2.5.3. Rest of South America

10.1. Key Insights

10.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
10.2.1. By Technology
10.2.2. By Specimen
10.2.3. By Product
10.2.4. By Application
10.2.5. By Country

11.1. Key Insights

11.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
11.2.1. By Technology
11.2.2. By Specimen
11.2.3. By Product
11.2.4. By Application
11.2.5. By Country

12.1. Key Insights

12.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
12.2.1. By Technology
12.2.2. By Specimen
12.2.3. By Product
12.2.4. By Application
12.2.5. By Country

13.1. Key Insights

13.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
13.2.1. By Technology
13.2.2. By Specimen
13.2.3. By Product
13.2.4. By Application
13.2.5. By Country

14.1. Key Insights

14.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
14.2.1. By Technology
14.2.2. By Specimen
14.2.3. By Product
14.2.4. By Application
14.2.5. By Country

15.1. Greiner Bio One International GmbH
15.2. Advanced Cell Diagnostics Inc.
15.3. Aviva Biosciences
15.4. Biocept, Inc. 
15.5. BioFluidica
15.6. Bio-Techne Corporation
15.7. Creatv Micro Tech Inc.
15.8. Fluxion Biosciences, Inc.
15.9. LungLife AI Inc.
15.10. Menarini Silicon Biosystems
15.11. Miltenyi Biotec
15.12. Precision for Medicine 
15.13. QIAGEN
15.14. Rarecells Diagnostics
15.15. ScreenCell
15.16. Sysmex Corporation
15.17. Other Prominent players